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Abstract
Neurodegenerative disorders such as Alzheimer’s disease are characterized by
damage to neural cells causing widespread neurological deficits. Historically, these
diseases were deemed as inevitable declines in cognitive and neurological function that
occurred with aging. Recent research has revealed, however, that these diseases have
molecular bases allowing potential clinical intervention. The groundbreaking discoveries
have been made using differing model organisms, which can replicate the phenotype
and physiological cause of these disorders. One major model organism that has been
used is the fruit fly, Drosophila melanogaster. They have served various roles in
elucidating gene pathways and neurophysiological bases seen in these diseases.
Current research using Drosophila is attempting to further characterize the molecular
basis along with potential clinical treatments. These new in-depth studies are in part a
result of advancing methodologies, which allows greater flexibility in the types of
experiments that can be done with Drosophila.

Introduction
1.1 Summary of major neurodegenerative disorders
Some of the major neurodegenerative diseases researched today are Alzheimer’s
disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD). They each
have their own known pathophysiology along with symptomatic presentation.
AD is a disease that normally appears in those over the age of 65. One of its initial
symptoms is memory deficit. As the disease progresses, other symptoms begin to
develop such as aphasia, motor dysfunctions, emotional liability, etc. The accumulations
of amyloid beta proteins and tau proteins are considered to be the primary causes of
AD. The toxic amyloid beta originates from cleavage of its precursor protein, APP, by
gamma secretase. The amyloid beta fragments then stick together to form plaques,
which activate the immune system causing inflammation and thus neural cell death. Tau
protein, which normally plays a role in regulating microtubules in brain cells, can
become hyperphosphorylated and lose its biological function. This lack of microtubule
regulation can lead to degradation of the synapses along with other cellular issues1.

Figure 1. Figure demonstrating cleavage of APP by beta, and then gamma secretase
leading to amyloid beta fragments. Image obtained from Zhang et al 2
PD is a disease characterized by motor deficits that also typically appears in elderly
individuals. The motor defects are one of the primary symptoms that have been
researched and observed, but there are multiple other non-motor symptoms as well.
These include cognitive declines, sleep disruptions and problems with autonomic body
functions. The cause of PD is not well documented, but the loss of dopaminergic
neurons in the substantia nigra tends to be observed along with lewy body deposition.
Some factors that are thought to play a role in the development of PD include genetic
factors, environmental toxins, and other damages to neural tissues causing potential
protein misfolding. The two major genes believed to be implicated are PINK1 and
PARKIN, which play a role in triggering autophagy due to damaged mitochondria3,4.
HD is another neurodegenerative disease characterized by movement deficits that
usually develops in people in their 30’s to 50’s. The primary symptoms are motor
deficits that include loss of coordination and involuntary movements. Similar to PD, nonmotor symptoms also begin to appear such as depression and other cognitive effects.
The genetic basis of HD is known to involve more than 36 CAG trinucleotide repeats in
the huntingtin (HTT) gene, which interferes with protein function and the subsequent
neural degeneration. Not much is currently known about the normal function of
huntingtin protein5.

1.2 The Drosophila model
Drosophila melanogaster is an arthropod that is most commonly known as the fruit fly.
In the wild, they seek out rotting fruit or other plant matter, which they spend time
feeding on, and is the location where females eventually lay hundreds of eggs. The
eggs then hatch into a larval state after a period of 18-24 hours. The larva move around
and feed on where they were lain for about 4 days, and then subsequently enter a pupal
stage. The pupal stage lasts another 4 days, and then an adult emerges from the pupae
and lives around 40 to 120 days 6.

Figure 2. Figure demonstrating images of different stages of the lifecycle as obtained
from Fernández-Moreno et al6
D. melanogaster contain 4 chromosomes along with 13,600 genes. 2 of the
chromosomes which D. melanogaster contain are sex chromosomes, with XY resulting

in a sex of male, and XX resulting in a sex of female. Drosophila show sexual
dimorphism, with males being slightly smaller, having a dark bottom, and containing
hairs on their forearms called “sex combs.” Females are larger and are striped all the
way down their bottom. Unlike in mammals, where females undergo random Xchromosome inactivation to compensate for their double X chromosomes, in D.
melanogaster, males undergo X hyperactivation in which their x chromosomes
produces twice as much transcript7.
Drosophila are commonly used in the study of genetics, pathology, and neuroscience
due to the reasons listed above. They are cheap, and easy to maintain (only needing to
be kept in vials containing a source of food). Their means of reproduction and small
number of chromosomes enables easy genetic manipulation and a large group of
offspring containing a desired genotype. Their relatively short lifespan allows for
phenotypes to be observed throughout development, including degenerative
phenotypes in later stages of development. Due to D. melanogaster’s widespread use
as a model organism, much of their anatomy and genes are well characterized, allowing
in-depth studies on specific functions8.
1.3 Drosophila Neurodegenerative models
Drosophila have additionally emerged as a predominant model organism used for the
study of neurodegenerative diseases along with C. elegans. Anatomically, the nervous
system of D. melanogaster is well documented, with different cellular lineages such as
the mushroom body (aids in learning and memory) having specific genes and protein
products that are well known. Additionally, the neurophysiology is relatively similar to
humans, with communication between neural synapses being a result of
neurotransmitters such as GABA, acetylcholine, etc. There are also behaviors that
Drosophila exhibit relative to learning and memory that serve as parallel to human
behaviors, allowing for observations of specific deficits. Finally, there are many
Drosophila homologs to human genes observed in diseases. This allows for the
manipulation of the paralogs and subsequent phenotype observation9.
Their genetic makeup, along with various human homologs, are commonly exploited for
the use of neural research. The genotype can be manipulated to observe the resulting
phenotype via a change in the expression or mutation of already existing genetic
homologs, the insertion of human genes known to cause neural disease, or through the
insertion of RNAi suppressors to modify gene expression. The insertion of human
disease genes can be used to create many neurodegenerative models. For example,
there can be an amyloid beta gene inserted to model AD, or an HTT mutant inserted to
model HD9.
One of the major ways this is achieved is through the elav-Gal4/UAS system. Elav
(embryonic lethal abnormal visual) is a RNA-binding protein that is present in the
nervous system of Drosophila throughout its development10. Gal4 is a yeast derived
transcriptional activator protein that contains no normal targets in flies and is inserted

into Gal4/UAS models. UAS (upstream activation sequence) is an enhancer region that
is activated by the transcriptional activator protein Gal4. In this transgenic setup, one
parental line will have the elav-Gal4 gene, whereas the other line will have a UAS
paired with the gene being expressed. When the lines are crossed, the ELAV protein
will drive the Gal4 expression in the nervous system. The Gal4 will subsequently bind to
the UAS enhancer causing the expression of the desired gene. These transgenic lines
are usually produced at lab supply centers such as Bloomington stock, but can also be
generated in lab via insertion of the desired vector into embryos11.
The neurodegenerative D. melanogaster models demonstrate various phenotypes that
can be indicative of the resulting neurodegeneration. One of the most general
observable phenotypes is a reduced lifespan, which is caused by increased levels of
toxic proteins that lead to neurodegeneration. Another observable phenotype is a
decrease in motor function, caused by motor regions of the CNS being deteriorated.
This can be demonstrated in Drosophila via the use of “negative geotaxis assays,”
which take advantage of Drosophila’s tendency to move against gravity. When
significant motor degeneration has occurred, the flies can be observed failing to move
up to the top of their containers as they normally would. Another observable phenotype
from neurodegeneration is a loss of memory and learning. This can be observed in
Drosophila models via courtship assay’s, which measure a male’s ability to remember
and learn from rejection12.
To conduct further research to elucidate functions related to specific neurodegenerative
pathologies, additional manipulation of models will usually take place. To develop a
further understanding of genetic interactions, additional genes can be inserted or
manipulated into well-established models. For example, a gene expected of preventing
neurodegeneration can be upregulated in an AD model and compared with the control
AD model to observe its effect. To check for potential external factors involved in
pathology, lifestyle changes can be enacted on the Drosophila such as prevention of
sleep in a PD model. Additionally, potential therapeutics can be tested by adding them
to food and then observing phenotype changes of the experimental group versus the
model. These manipulations are a few of the examples that are currently being used by
researches in the field to find the biological basis behind neurodegeneration.

2. Current Research Breakthroughs Using Drosophila
2.1 Autophagy
Autophagy is one of the mechanisms through which damaged cells and tissues are
removed in multicellular organisms. This process has been demonstrated to have an
important relationship with neurodegeneration, as cells containing toxins, damage, or
misfolded proteins can be safely discarded in non-pathological tissue. The general
mechanism of autophagy involves lysosomal digestion of the cell through 3 differing
mechanisms. The first is chaperone-mediated autophagy, where specific proteins with

defects are identified and then marked and sent to the lysosome for digestion. This
mechanism allows for specific proteins with deficits to be disposed of. The next major
form of autophagy is microautophagy, which is characterized by the lysosome directly
taking up specific parts of the cell. This allows for specific areas of the cell that may
contain toxins to be disposed of. The final major type of autophagy is macroautophagy,
which is characterized by the formation of the autophagosome which fuses with the
cell’s lysosome. The resulting autolysosome then allows for its contents to be broken
down. This process is the major one that research is currently being done on in relation
to neurodegeneration13.

Figure 3. A figure demonstrating the major autophagic processes as described above.
Obtained from Mizushima et al14
It is currently being discovered that autophagy plays a key role in the maintenance of
the nervous system. Some of the major aspects of neurons that are maintained by
autophagy and found to be important in the degradative process are defective
mitochondria and proteins found in the axon and synapse. The defective proteins found
in the synapse and axons can be observed in neurodegenerative disease such as AD,
where the mutant Amyloid beta and tau protein accumulate13.
As genes that are critical for autophagy in the nervous system are being investigated,
they are being found to play a role in neuronal aging as well as degeneration. One of
the major classes of genes being looked into are the Atg genes13. This family of genes
contains proteins that form complexes with each other that play a role in the
development of the autophagosome. Deficits in these genes can hinder the formation of
the autophagosome and cause neuronal degradation and shortened lifespan, with one
known example being Atg115. Additionally the loss of Atg5 or Atg7 in Drosophila leads to

a similar histology (protein aggregates, neurodegeneration) and phenotype (climbing
defect, memory defects, and shortened lifespan) to that which is typically seen in
neurodegenerative models16.
Another gene pathway involved in autophagy that is currently being demonstrated to
have a relationship with neuronal maintenance are SNARE proteins13. SNARE proteins
are proteins that play an important role in vesicle fusion. One of the SNARE genes
investigated to play a role in autophagy is Syx17 (Syntaxin 17). The Drosophila Syx17
mutants were found to have reduced locomotive ability along with shortened lifespans,
similar to that seen in neurodegenerative models. With the Syx17 mutants, there was an
observed accumulation of autophagosome along with protein aggregates seen in the
CNS17.
Another study demonstrating the role of autophagy in neuronal maintenance looks at
the effects of upregulating autophagy on nervous system health. It was found that
enhancing the level of Atg8 protein in adult Drosophila resulted in effects such as
enhanced lifespan and a reduced presence of protein aggregates. The average adult
lifespan increased about 56% as compared to a non Atg upregulated control, and a 12
fold reduction in protein aggregates was observed. Additionally, upregulated autophagy
was found to increase the neural resistance to reactive oxidative species, which is a
major known risk factor for neural degeneration18.
2.2 Mitochondrial changes
Mitochondria have been found to function in the pathology of various neurodegenerative
diseases, with some type of mitochondrial dysfunction being noted in the 3 that are
discussed. Mitochondria typically function in neurons by carrying out energy production,
metabolism of nutrients, senescence, and eventual apoptosis or necrosis of neurons19.
Some of the mechanisms being investigated related to a mitochondrial role in
neurodegeneration include a problem with mitochondrial fusion/fission, alterations to
mitochondrial metabolism, calcium homeostasis, and regulation of cell
death/autophagy20.
In PD, an impairment to the complex I region of the mitochondria has been observed.
This affects the mitochondrial ability to carry out dopaminergic cell death, as well as
increases the amount of free radicals that are found in neurons. The defect with the
complex I region of the mitochondria leads to a higher number of free radicals within the
cell, requiring heightened activation of the antioxidant system to reduce the levels to
normal. The increased presence of ROS can cause reactions and change the formation
of important cellular molecules like lipids that constitute the membrane along with
various cellular proteins. The damage to these cellular components leads to the neural
degeneration seen in PD and other similar diseases21.
Calcium homeostasis is an important part of normal cellular functions. Additionally, high
levels of calcium found in the cell can lead to cell death. The mitochondria play an
important role in buffering intracellular calcium levels through calcium uptake.

Mitochondrial dysfunction along with calcium dysregulation has been observed in
various neurodegenerative disorders such as AD, PD, and HD. Defects in the ERmitochondrial contact sites are also frequently observed in these diseases. In AD,
problems with calcium maintenance and mitochondria appear before any obvious
protein aggregates. Additionally, neurons in AD models were shown to have an
increase in ER/Mitochondrial connections. For PD, some of the major genes such as
Parkin and PINK1 have roles in maintaining calcium homeostasis. While there is shown
to be a relationship between calcium homeostasis and neurodegeneration, an exact
mechanism is still unknown22. Current research is looking into the specific mechanisms
through which calcium dysregulation causes the aforementioned changes in
neurodegeneration. For example, Popugaeva et al23 delves deeper into the specific
proteins that require proper calcium levels for homeostasis and the resulting effects of
dysregulation. In AD, these include the development of toxic protein plaques, synaptic
weakening, etc.23.
As discussed above in 2.1, autophagy and cell death can serve important roles in
preventing the build-up of dysfunctional cells and toxic proteins. However, if the process
of cell death is not regulated properly, healthy cells and tissue can die. This can be in
part due to the failure of the mitochondria in regulating calcium levels, leading to an
increase in reactive oxygen species, and thus cell death. It appears that defects with the
mitochondrial calcium uniporter has a relation to neurodegeneration from oxidative
stress24.

Figure 4. A figure demonstrating the role of the mitochondrial calcium uniporter in the
cell. This is one of the mechanisms by which mitochondria regulate calcium in a healthy
cell. Image obtained from Kannurpatti25

2.3 Synaptic degeneration
One of the major hallmarks seen in any neurodegenerative disease is a decline is
synaptic processes. Synapses in a healthy CNS work to allow communication between
neurons and thus allow the CNS to function as a whole. In most neurodegenerative
illnesses, even before cell death is observed, there are changes seen in synapses.
These include a decrease in the amount of individual synapses, alterations to synaptic
structure, and changes to both pre and post synaptic structures. These changes can be
seen in various diseases such as AD, PD, and HD26.
Synaptic function plays a key role in memory, which is one of the most obvious deficits
in AD patients and models. One of the proposed mechanisms by which synaptic
function can be dysregulated in AD models involves the improper activation of microglial
cells. These cells normally play an important role in the neurological immune system
and function to remove damaged neurons. When they are exposed to amyloid beta, it is
thought that they function incorrectly and can degrade important synaptic structures27.
Another mechanism for the early development of memory deficits is the reduction in
gene expression of proteins important for synaptic transmission. This is thought to occur
with the expression of amyloid beta28.
In non-pathological neurons, the proteins PINK1 and PARKIN work together to cause
the degradation of damaged mitochondria. When PINK1 is mutated, as seen in PD, the
failing mitochondria cannot be removed. As mentioned in 2.2, mitochondrial defects can
lead to an accumulation of ROS, dysregulation of calcium homeostasis, along with
energetic deficits of the cell. While extreme accumulations of defective mitochondria can
result in inappropriate neuronal death, synaptic function can also be hindered with minor
levels of mitochondrial dysfunction. This is due to the high reliance of synaptic release
of neurotransmitters on mitochondria-regulated processes. The packaging of
neurotransmitters into vesicles and eventual exocytosis requires a large amount of ATP.
Additionally, calcium is the ionic trigger which signals the release of neurotransmitters.
When there is calcium dyshomeostasis and energetic deficits due to dysfunctional
mitochondria, communication is hindered at the synapses. In Doktór et al3, they further
demonstrate that Drosophila PINK1 mutations lead to a decrease in the presynaptic
protein BRP, which aids in the accumulation of calcium channels for neurotransmitter
release3.
The Htt protein’s primary functions in non-pathological tissues are not well documented.
It is known that HTT can be found on some membranes and plays a role in endocytosis.
In Akbergenova and Littleton29, an increase in synaptic connections was noted due to
an increase in BMP signaling. They attributed the increase in BMP signaling to

pathogenic Htt blocking the termination of the BMP receptor. The pathologic Htt is seen
to prevent proper exchange of vesicles at the synapse in Drosophila models. This leads
to an inability for communications between neurons or at the neuromuscular junction29.

2.4 Summary of current research direction
The bulk of neurodegenerative research in Drosophila is looking into genes related to
specific disease processes. These include studies into the prevalence of certain
phenotypic deficits, histological changes, and molecular changes. While these studies
typically attempt to elucidate specific disease mechanisms, there are some
commonalities found between the different neurodegenerative disorders. These
common traits present in different ways in each disease as noted above. Despite the
differences, the connections between the mechanisms of disease progression can be
used to draw conclusions about overall neurodegenerative disease progression.
There are extensive studies in Drosophila to expand upon the exact mechanisms and
genetic involvement seen in the varying neurodegenerative disorders. One of these
areas of research involves the progression of cell death, which is a crucial hallmark of
all neurodegenerative diseases. This has been demonstrated to occur via various
processes in the major neurodegenerative diseases. In AD, one of the primary causes
of neuronal cell death is related to build ups of toxic protein. In PD, damaged
mitochondria can abnormally signal the process of cell death. Finally, in HD there is
some dysregulation of the autophagic process observed causing inappropriate cell
death30. In addition to neuronal death being observed in these diseases, there is similar
mechanistic pathways through which they progress. One of the most common vectors
of progression involves dysregulated autophagy. This can cause an excessive amount
of cell death in cells with accumulated toxic proteins or mitochondrial deficits. It can also
cause a lack of autophagy in cells that are damaged, leading to a buildup of defective
cells. These pathways of degeneration are linked to the mitochondrial dysfunction and
calcium dyshomeostasis as outlined above.
Research on Drosophila is also currently looking into mitochondrial function in
neurodegenerative diseases. Again, the specific mechanisms vary between the different
diseases in the cause of mitochondrial-based degeneration. The major processes that
are thought to be involved are alterations to aerobic metabolism causing ROS buildups,
calcium dysregulation, and also their role in autophagy. Current research is looking into
the specific gene pathways that are involved in the pathologic processes. The general
findings that are noted include the discovery that the mitochondria can be the key
source of the problems found in the other areas of pathological problem. The
mitochondria play key roles in mediating cell death. Calcium, which is regulated by
mitochondria, plays a role in abnormal neural death as well as autophagy. Additionally,
mitochondria are being researched due to their importance in proper synaptic function.

When there is a dysfunction in mitochondria, synapses are one of the first areas of the
nervous system to begin showing deficits.
Synaptic function is an additional major area of research currently being conducted.
This is partially due to the importance of synapses to the function of memory and neural
health, which is shown to decline in the different neurodegenerative diseases. Many
separate studies into differing sources of neurodegeneration demonstrate some form of
synaptic dysfunction. Current research is looking into the different regions of the
synapses that are the source of the issue. It has been found that presynaptic structures,
and release of vesicles cannot function properly with dysfunctional mitochondria. Also,
specific genes have found to be important in the release of the synaptic vesicles, and
the receiving of neurotransmitters from the previous neuron. Dysfunctions in any of
these processes can lead to improper neuronal communication.

2.5 Therapeutic applications
Treatments and therapeutics have historically been limited in neurodegenerative
disorders due to a limited understanding of the diseases’ molecular mechanisms.
Recent research is helping to break down this barrier, and open the doors for studies
into different therapeutics. While for most neurodegenerative diseases a complete
remedy is still far off, different therapeutics are still being developed now. These
therapeutics would work by interfering with the pathological processes that are being
discovered in currently evolving research.
In AD, there has been a large amount of focus on the amyloid beta pathway of neural
degeneration. This has led to a focus on development of anti-amyloid beta drugs, which
have not demonstrated much success in symptomatic relief. One major therapeutic
possibility involves intervention in the calcium pathway. The excessive calcium
presence leads to weakened synapses through long term depression mechanisms. This
is responsible for some of the memory loss observed in AD patients, and is an early
hallmark for AD. Popugaeva et al23 proposes several different therapeutic approaches
based on the different levels of calcium dyshomeostasis as a result of ER leak
channels. One of these includes direct inhibitor treatments of the membrane protein
responsible for the calcium leak. It also proposed potential treatments to the
downstream proteins that are affected by the abnormal calcium levels23.
Understanding the function of certain proteins that are found in neurodegenerative
diseases is crucial for furthering research into therapeutic possibilities. One protein that
is currently being researched for its relation to Lewy Body Dementia, AD, and PD is
alpha synuclein. Alpha synuclein has been shown to aggregate and form Lewy bodies,
which are found in the progression of PD. Accumulations of this protein are additionally
found in various types of neurons in PD patients and models31. Alpha synuclein, along
with the other known PD genes such as PINK1 and Parkin, have been demonstrated to
participate in mitochondrial function and clearance. Specifically, alpha synuclein has

recently been observed interacting with Miro, which is a protein that is required to be
removed from the outer mitochondrial membrane before mitophagy can be initiated.
Mitophagy is an important process for disposing of damaged mitochondria. This is
important for neurons due to the reasons discussed in 2.2, as damaged mitochondria
can quickly cause problems with proper neural functioning. When alpha synuclein
beings to accumulate, Miro protein has been found to be upregulated. When the
expression of Miro is downregulated in Drosophila PD models, a significant decline in
both locomotive defects and neurodegeneration was observed. This demonstrates that
a therapeutic that works to reduce alpha synuclein (and thus Miro) could aid in reducing
degradation seen in PD32.
In HD, mutant HTT plays a large role in the progression of the disease. It has a toxic
effect on neurons, causing eventual neurodegeneration. After mutant HTT is produced,
it undergoes many changes that play a role in its toxicity and function in the neurons.
One of these changes include ubiquitination, a process that normally functions in
marking the degradation of a protein within the cell. Ubiquitin proteasome system is a
protein that plays a role in ubiquitination and the autophagy clearance pathway. When
this is protein is stimulated, autophagy can occur in cells containing toxic proteins. This
allows for neurons to clear toxic cells that can spread neurodegenerative proteins. Other
proteins that play a role in the autophagic process could serve to aid in treating HD,
along with other neurodegenerative disorders33.

3. Current Research Methodology in Drosophila research
3.1 Transgenic lines
Drosophila have been used to obtain a large portion of the above information, and are
one of the crucial models for neurodegenerative research. Before determining specific
pathways by which the diseases progress, a common model had to be established.
Drosophila research is heavily dependent on having a common model for which to base
studies on particular diseases. These models are achieved through various types of
transgenic lines. These transgenic lines can be generated in a lab via vector insertion
and crossing, or more commonly received from a stock center that creates specific
models. One of the frameworks through which neurodegenerative Drosophila models
are typically created is the Elav-gal4 uas line which is discussed above in 1.3. This
general outline of the processes of transgenic lines include inserting a gene that
produces proteins known to be heavily involved in the production of neural deficits.
These genes’ expression are then driven by tissue specific transcription factors, which
allow expression in desired tissues. Key genes have generally been used for each
disease model, however there are variants of each gene which produce slightly different
pathologies34.
The primary type of gene insertion for HD models include HTT genes with CAG repeats.
The main types of variation that is found in the inserted genes in transgenic HD lines

involves varying amount of glutamine repeats. The different amounts of variations cause
phenotypic variations in severity, onset, as well as differences in the eye structure.
Overall, Drosophila HD models tend to display a decrease in motor function, and
shortened lifespan. In addition to just the HTT protein, some common models include
different protein expressions that are thought to interact with the HD pathway. These
include chaperone proteins that can either alleviate or worsen the phenotype, as well as
proteins that play a role in autophagy35.
Models for AD in Drosophila typically include some variation of the amyloid beta protein
or tau combined with the Elav-gal4 model. The amyloid beta gene that is included in the
transgenic lines is typically a directly toxic variant of amyloid beta such as amyloid beta
42 or 40. It can also be the precursor of which this toxic protein is formed. This includes
an APP protein and the gene that encodes for the enzyme that cleaves it into its toxic
variant, beta-secretase or BACE. This can be used to observe pathways that involve the
formation of amyloid beta. Another gene that is inserted to generate the transgenic lines
is tau, which can be included with the amyloid beta genes. Additional variant models
include genes thought to have some relationship to the development including ApoE
and presenilin. When these genes are inserted or crossed into the Elav-gal4 model,
similar neurodegenerative declines to the amyloid beta models are observed36.
Similar to the other neurodegenerative models, PD in Drosophila is modeled through
inserted genes that produce a similar phenotype to human PD. These genes include
multiple mutant variants of “PARK” with some of the significant ones being SNCA,
parkin, Pink1, DJ-1, and LRRK2. They all induce similar phenotypes and cause
increased ROS and mitochondrial damage, but with differences among the mechanisms
through which they function. The phenotypes of these different PD models usually
include locomotive defects, shortened lifespan, wing muscle weakening, dopaminergic
neuron loss, and sometimes retinal degeneration21.

3.2 Further Manipulation of Models
The above models are the origin of how to replicate the diseases in Drosophila. In order
to conduct research on molecular mechanisms in Drosophila, additional manipulation of
the models is required. Researches do this via physical manipulation of the model, the
introduction of external substances, or further genetic manipulation. Further physical
manipulation could include exposure to exercise or increased darkness. The
introduction of external substances could include the addition of alcohol in the food of a
PD model. Finally, further genetic manipulation could include the insertion of an RNAi
vector to observe the downregulation of another gene. All of these methods help to
elucidate further processes behind the disease. These manipulations are then paired
with subsequent observation of molecular and phenotypic changes to demonstrate what
processes are being affected.

Varying physical factors has long been used as a method to observe phenotypic
changes in model organisms. These factors are important as they represent normal
behavioral variations in disease progression that would normally be seen in humans.
Researchers have developed creative methodologies to achieve these same variation in
animal models. One example of this type of manipulation is seen in the blue light
experiments of Nash et al37. In this study, Drosophila were exposed to a different light
conditions and subsequent neurodegeneration was observed. Another example of
physical factor manipulation is seen in the exposure to exercise as seen in Berlandi et
al38. This study utilized a “swing boat” to expose groups of Drosophila to exercise, and
then observed a subsequent relation to changes in neurodegeneration.

Figure 5. Figure depicting the Swing Boat as used in Berlandi et al38
The inclusion of external substances to neurodegenerative Drosophila models is
another important consideration. These inclusions are important to test the effects of
chemicals in disease progression that humans are normally exposed to. These can
include chemical exposures to substances such as pesticides in PD, or a study looking
to connect alcohol with neurodegeneration. These types of experimental modifications
are also important for the testing of potential therapeutics. The addition of potential
therapeutics and subsequent observation can be used to further expand upon disease
processes, or demonstrate substances that could be beneficial. These external
substances are typically given to the models through their food. An example of a study
that uses this type of manipulation is Mattioli et al39, in which Drosophila are given food
containing a plant extract containing polyphenols.
Another type of alteration made to Drosophila models is further genetic manipulation,
where genetic expressions in the model are modified to help elucidate cellular pathways
and related genes. This is achieved through direct changes to genes, insertion of
additional genes, or alteration of gene expression through RNAi. Changes to genes
could include site directed mutagenesis in which individual nucleotides can be altered.

Including additional genes in the lines can elicit phenotypic changes with interactions
between the inserted genes, such as including tau in the amyloid beta models. Finally,
alterations of gene expression through RNAi allows the monitoring of specific native
genes relating to disease progression. This method is used in Abul Khair et al40, in
which an RNAi knockdown of a glucocerebrosidase gene is included in a PD model.
The resulting molecular and phenotypic changes in relation to control PD models was
then observed.

3.3 Methods for Observing Effects of Manipulation
After the additional changes have been made to the neurodegenerative Drosophila
models, procedures are carried out to view the changes to the model. These include
both methods of observing phenotypic changes and molecular changes. To observe
neurological phenotypic changes, the most common assays done measure the model’s
locomotive ability, lifespan, and memory. To observe the molecular changes, typical
molecular lab procedures are carried out including protein analysis, nucleic acid
analysis, and immunohistochemistry.
The different assays to observe phenotypic changes are done by taking advantages of
some of Drosophila’s unique properties. As discussed in 1.3, locomotor assays are
done to observe any changes to the models motor ability. This is accomplished by
taking advantage of Drosophila’s negative geotaxis, or movement against gravity.
Locomotor assays take place by trapping a fly in a container, and then observing the
amount that can make it to the top within a limited time. In PD, HD, and advanced AD
models, the locomotive ability of the flies tends to decrease. Memory assays are done
by taking advantage of the male flies’ ability to learn during courtship. When male flies
are rejected by female flies that have already mated, they “learn” to stop trying for a
period of time after, even when exposed to virgin female flies. In models where memory
loss is present, such as AD models, this learning process is stunted and male flies will
persist. While these are the fundamentals behind the assays, certain adjustments can
be made by researchers. These phenotypic assays are performed to observe the
effects of the model changes discussed in 3.212.
The molecular procedures are done to directly observe changes to the model’s genome,
gene expression, or protein presence. The common methods of nucleic acid
observation include gel electrophoresis of DNA or cDNA from RT-PCR (reversetranscriptase-polymerase chain reaction). These are done to verify gene presence.
Gene expression can then be measured through qPCR or western blots. A combination
of these methods are typically carried out to observe the relationship between inserted
genes and their effect on other gene expression or protein presence. This can also be
taken a step further in immunohistochemistry. In neurodegenerative Drosophila models,
this is typically done by creating thin slices of the brain and then staining with specific
antibodies. Proper imaging can then show the protein of interest’s presence in the brain,

and potential neurodegeneration. These, along with other methods of observing
molecular changes, are used to verify changes caused by additional factors in the
disease pathway41.

4. Future Direction of Neurodegenerative Research in Drosophila
Up to this point, research in Drosophila has greatly expanded the understanding of
specific neurodegenerative diseases along with the general neurodegenerative process.
The current research direction consists of an expanding understanding of the processes
of these diseases and other involved genes. Additionally, there is a push to test for
potential therapeutics that can help with neurodegeneration and even potentially repair
damages done. This is a major goal in neurodegenerative disease research among all
models, as currently used therapeutics only work to target symptoms, rather than
disease origin. Going forward, there will be further work done to develop a clear cellular
pathway for the different diseases. Understanding the genes and proteins involved is
vital for a therapeutic which can hinder or halt disease progression. Although each
disease has its own genes and origins, current research is demonstrating there may be
similar pathways among them. One such recently published study reveals that mutant
HTT protein in HD consists of similar aggregation and properties to the amyloid beta
protein in AD42. Further studies demonstrating these similar properties will be important
for a holistic understanding of disease progression. Another future direction of
neurodegenerative research involves the reversal of neuronal damages. While
neurogenesis in adult brains only occurs in certain areas43, neuronal processes can
grow and change throughout adulthood. One aspect of this, axonal regeneration, is
currently being discussed as a means to maintain synapses despite damages44.

5. Conclusion
A significant portion of what is known today about the nervous system and the diseases
that affect it have been obtained from research on D. melanogaster. At a glance, HD,
PD, and AD may seem to occur via differing mechanisms that occur from various
genetic causes. From the many studies on neurodegeneration being done by
researchers from around the world, commonalities are beginning to be drawn between
the different degenerative processes. These include defects in the neurons ability to
carry out autophagy, proper mitochondrial function, and synaptic degeneration. While a
clear connection is not well understood at the time, research is currently being
conducted to clarify these processes and how to halt them. As Drosophila has proven to
be vital in past research into these diseases, they will also play a key role in the road
ahead.

References
1. Bondi, M. W., Edmonds, E. C. & Salmon, D. P. Alzheimer’s Disease: Past, Present,
and Future. J Int Neuropsychol Soc 23, 818–831 (2017).
2. Zhang, C. et al. Amyloid-β production via cleavage of amyloid-β protein precursor is
modulated by cell density. J Alzheimers Dis 22, 683–984 (2010).
3. Doktór, B., Damulewicz, M., Krzeptowski, W., Bednarczyk, B. & Pyza, E. M. Effects
of PINK1 mutation on synapses and behavior in the brain of Drosophila
melanogaster. Acta Neurobiol Exp (Wars) 78, 231–241 (2018).
4. Sveinbjornsdottir, S. The clinical symptoms of Parkinson’s disease. J Neurochem
139 Suppl 1, 318–324 (2016).
5. Roos, R. A. C. Huntington’s disease: a clinical review. Orphanet J Rare Dis 5, 40
(2010).
6. Fernandez-Funez, P., de Mena, L. & Rincon-Limas, D. E. Modeling the complex
pathology of Alzheimer’s disease in Drosophila. Experimental Neurology 274, 58–71
(2015).
7. Gergen, J. P. Dosage Compensation in Drosophila: Evidence That daughterless and
Sex-lethal Control X Chromosome Activity at the Blastoderm Stage of
Embryogenesis. Genetics 117, 477–485 (1987).
8. Hirth, F. Drosophila melanogaster in the study of human neurodegeneration. CNS
Neurol Disord Drug Targets 9, 504–523 (2010).
9. Chan, H. Y. & Bonini, N. M. Drosophila models of human neurodegenerative
disease. Cell Death Differ 7, 1075–1080 (2000).

10. Koushika, S. P., Lisbin, M. J. & White, K. ELAV, a Drosophila neuron-specific
protein, mediates the generation of an alternatively spliced neural protein isoform.
Curr Biol 6, 1634–1641 (1996).
11. Omega-3 fatty acids in brain and neurological health. (Elsevier/Academic Press,
2014).
12. Nichols, C. D., Becnel, J. & Pandey, U. B. Methods to assay Drosophila behavior. J
Vis Exp (2012) doi:10.3791/3795.
13. Maruzs, T., Simon-Vecsei, Z., Kiss, V., Csizmadia, T. & Juhász, G. On the Fly:
Recent Progress on Autophagy and Aging in Drosophila. Front Cell Dev Biol 7, 140
(2019).
14. Mizushima, N., Levine, B., Cuervo, A. M. & Klionsky, D. J. Autophagy fights disease
through cellular self-digestion. Nature 451, 1069–1075 (2008).
15. Juhász, G., Erdi, B., Sass, M. & Neufeld, T. P. Atg7-dependent autophagy promotes
neuronal health, stress tolerance, and longevity but is dispensable for
metamorphosis in Drosophila. Genes Dev 21, 3061–3066 (2007).
16. Varga, K. et al. Loss of Atg16 delays the alcohol-induced sedation response via
regulation of Corazonin neuropeptide production in Drosophila. Sci Rep 6, 34641
(2016).
17. Takáts, S. et al. Autophagosomal Syntaxin17-dependent lysosomal degradation
maintains neuronal function in Drosophila. J Cell Biol 201, 531–539 (2013).
18. Simonsen, A. et al. Promoting basal levels of autophagy in the nervous system
enhances longevity and oxidant resistance in adult Drosophila. Autophagy 4, 176–
184 (2008).

19. Itoh, K., Nakamura, K., Iijima, M. & Sesaki, H. Mitochondrial dynamics in
neurodegeneration. Trends Cell Biol 23, 64–71 (2013).
20. Area-Gomez, E., Guardia-Laguarta, C., Schon, E. A. & Przedborski, S.
Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.
J Clin Invest 129, 34–45 (2019).
21. Aryal, B. & Lee, Y. Disease model organism for Parkinson disease: Drosophila
melanogaster. BMB Reports 52, 250–258 (2019).
22. Lee, K.-S. et al. Altered ER-mitochondria contact impacts mitochondria calcium
homeostasis and contributes to neurodegeneration in vivo in disease models. Proc
Natl Acad Sci U S A 115, E8844–E8853 (2018).
23. Popugaeva, E., Pchitskaya, E. & Bezprozvanny, I. Dysregulation of neuronal
calcium homeostasis in Alzheimer’s disease - A therapeutic opportunity? Biochem
Biophys Res Commun 483, 998–1004 (2017).
24. Choi, S. et al. Mitochondrial calcium uniporter in Drosophila transfers calcium
between the endoplasmic reticulum and mitochondria in oxidative stress-induced
cell death. J Biol Chem 292, 14473–14485 (2017).
25. Kannurpatti, S. S. Mitochondrial calcium homeostasis: Implications for
neurovascular and neurometabolic coupling. J Cereb Blood Flow Metab 37, 381–
395 (2017).
26. Parra-Damas, A. & Saura, C. A. Tissue Clearing and Expansion Methods for
Imaging Brain Pathology in Neurodegeneration: From Circuits to Synapses and
Beyond. Front Neurosci 14, 914 (2020).

27. Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer
mouse models. Science 352, 712–716 (2016).
28. Sekiya, M. et al. Integrated biology approach reveals molecular and pathological
interactions among Alzheimer’s Aβ42, Tau, TREM2, and TYROBP in Drosophila
models. Genome Medicine 10, (2018).
29. Akbergenova, Y. & Littleton, J. T. Pathogenic Huntington Alters BMP Signaling and
Synaptic Growth through Local Disruptions of Endosomal Compartments. J
Neurosci 37, 3425–3439 (2017).
30. Bano, D., Zanetti, F., Mende, Y. & Nicotera, P. Neurodegenerative processes in
Huntington’s disease. Cell Death Dis 2, e228 (2011).
31. Yedlapudi, D. et al. Targeting alpha synuclein and amyloid beta by a multifunctional,
brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in
Parkinson’s disease with dementia. Sci Rep 9, 19648 (2019).
32. Shaltouki, A., Hsieh, C.-H., Kim, M. J. & Wang, X. Alpha-synuclein delays mitophagy
and targeting Miro rescues neuron loss in Parkinson’s models. Acta Neuropathol
136, 607–620 (2018).
33. Aron, R. et al. Deubiquitinase Usp12 functions noncatalytically to induce autophagy
and confer neuroprotection in models of Huntington’s disease. Nat Commun 9, 3191
(2018).
34. Lu, B. & Vogel, H. Drosophila models of neurodegenerative diseases. Annual
Review of Pathology 4, 315–342 (2009).
35. Sang, T.-K. & Jackson, G. R. Drosophila models of neurodegenerative disease.
NeuroRx 2, 438–446 (2005).

36. Tan, F. H. P. & Azzam, G. Drosophila melanogaster: Deciphering Alzheimer’s
Disease. Malays J Med Sci 24, 6–20 (2017).
37. Nash, T. R. et al. Daily blue-light exposure shortens lifespan and causes brain
neurodegeneration in Drosophila. NPJ Aging Mech Dis 5, 8 (2019).
38. Berlandi, J. et al. Swing Boat: Inducing and Recording Locomotor Activity in a
Drosophila melanogaster Model of Alzheimer’s Disease. Front Behav Neurosci 11,
159 (2017).
39. Mattioli, R. et al. Anti-Inflammatory Activity of A Polyphenolic Extract from
Arabidopsis thaliana in In Vitro and In Vivo Models of Alzheimer’s Disease. Int J Mol
Sci 20, (2019).
40. Abul Khair, S. B. et al. Silencing of Glucocerebrosidase Gene in Drosophila
Enhances the Aggregation of Parkinson’s Disease Associated α-Synuclein Mutant
A53T and Affects Locomotor Activity. Front Neurosci 12, 81 (2018).
41. McGurk, L., Berson, A. & Bonini, N. M. Drosophila as an In Vivo Model for Human
Neurodegenerative Disease. Genetics 201, 377–402 (2015).
42. Zhu, Y. et al. Nmnat restores neuronal integrity by neutralizing mutant Huntingtin
aggregate-induced progressive toxicity. Proc Natl Acad Sci U S A 116, 19165–
19175 (2019).
43. Aimone, J. B., Deng, W. & Gage, F. H. Adult neurogenesis: integrating theories and
separating functions. Trends Cogn Sci 14, 325–337 (2010).
44. Brace, E. J. & DiAntonio, A. Models of axon regeneration in Drosophila. Exp Neurol
287, 310–317 (2017).

